DermTech Inc (NASDAQ: DMTK) stock closed at 1.65 per share at the end of the most recent trading day (a -2.94% change compared to the prior day closing price) with a volume of 125.71K shares and market capitalization of 55.57M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 64 people. DermTech Inc CEO is John D Dobak.

The one-year performance of DermTech Inc stock is -59.91%, while year-to-date (YTD) performance is -6.78%. DMTK stock has a five-year performance of -91.82%. Its 52-week range is between 1.55 and 6.44, which gives DMTK stock a 52-week price range ratio of 2.04%

DermTech Inc currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 0.42, a price-to-sale (PS) ratio of 5.72, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -49.36%, a ROC of -52.51% and a ROE of -56.28%. The company’s profit margin is -%, its EBITDA margin is -762.00%, and its revenue ttm is $11.52 Million , which makes it $0.38 revenue per share.

Of the last four earnings reports from DermTech Inc, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.68 for the next earnings report. DermTech Inc’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for DermTech Inc is Moderate Buy (2), with a target price of $10.67, which is +546.67% compared to the current price. The earnings rating for DermTech Inc stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DermTech Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DermTech Inc has a Sell technical analysis rating based on Technical Indicators (ADX : 30.90, ATR14 : 0.16, CCI20 : -114.56, Chaikin Money Flow : -0.18, MACD : -0.22, Money Flow Index : 12.87, ROC : -18.72, RSI : 30.13, STOCH (14,3) : 6.43, STOCH RSI : 0.28, UO : 35.83, Williams %R : -93.57), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DermTech Inc in the last 12-months were: Akhavan Ramin (Sold 3 776 shares of value $9 553 ), Claudia Ibarra (Sold 12 955 shares of value $46 672 ), Dobak John (Sold 25 514 shares of value $102 340 ), Ibarra Claudia (Sold 20 519 shares of value $66 739 ), John D Dobak (Sold 25 514 shares of value $102 340 ), Kevin Sun (Sold 12 221 shares of value $48 662 ), Ramin Akhavan (Sold 17 278 shares of value $64 371 ), Sun Kevin M (Sold 8 253 shares of value $21 246 ), Todd Michael Wood (Sold 10 114 shares of value $38 999 ), Wood Todd (Sold 14 467 shares of value $50 345 ), Wood Todd Michael (Sold 5 342 shares of value $13 628 )